Author

Arpita Nag

SYMPTOM AND QUALITY OF LIFE BURDEN AMONG PATIENTS WITH EOSINOPHILIC OESOPHAGITIS IN A REAL-WORLD SETTING
SYMPTOM AND QUALITY OF LIFE BURDEN AMONG PATIENTS WITH EOSINOPHILIC OESOPHAGITIS IN A REAL-WORLD SETTING

Arpita Nag  et al.

ECONOMIC MODELS USED TO EVALUATE THE COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS FOR ULCERATIVE COLITIS: A SYSTEMATIC LITERATURE REVIEW
ECONOMIC MODELS USED TO EVALUATE THE COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS FOR ULCERATIVE COLITIS: A SYSTEMATIC LITERATURE REVIEW

Arpita Nag  et al.

SYSTEMATIC LITERATURE REVIEW TO ASSESS THE HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ULCERATIVE COLITIS IN ADULTS IN EUROPE
SYSTEMATIC LITERATURE REVIEW TO ASSESS THE HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ULCERATIVE COLITIS IN ADULTS IN EUROPE

Arpita Nag  et al.

DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE
DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE

Arpita Nag  et al.

PHYSICIAN PREFERENCES FOR BIOLOGICS FOR THE TREATMENT OF CROHN'S DISEASE AND ULCERATIVE COLITIS IN FRANCE, GERMANY AND THE UNITED KINGDOM
PHYSICIAN PREFERENCES FOR BIOLOGICS FOR THE TREATMENT OF CROHN'S DISEASE AND ULCERATIVE COLITIS IN FRANCE, GERMANY AND THE UNITED KINGDOM

Arpita Nag  et al.

TREATMENT PATTERNS AMONG PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE RECEIVING BIOLOGIC THERAPY IN FRANCE, GERMANY AND THE UNITED KINGDOM
TREATMENT PATTERNS AMONG PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE RECEIVING BIOLOGIC THERAPY IN FRANCE, GERMANY AND THE UNITED KINGDOM

Arpita Nag  et al.

Item 1 - 6 / 6
1